Fingerprint
Dive into the research topics of 'The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial
John A. Spertus, Mary C. Birmingham, Michael Nassif, C. V. Damaraju, Antonio Abbate, Javed Butler, David E. Lanfear, Ildiko Lingvay, Mikhail N. Kosiborod, James L. Januzzi
Research output: Contribution to journal › Article › peer-review
113
Scopus
citations